0

0

0

0

0

0

0

0

0

videos | IST

Glenmark Pharma's Q2 earnings today: Here’s what to expect

Mini

Glenmark Pharma will report its second-quarter earnings on Tuesday and the focus will be on the drugmaker's performance in the US market.

Glenmark Pharma will report its second-quarter earnings on Tuesday and the focus will be on the drugmaker's performance in the US market.
  • The US market has declined year-on-year for the past four quarters for Glenmark Pharma. The decline in the US market is due to high pricing pressure, high base due to cholesterol drug Zetia. So these are key reasons.
  • In Q1 of FY19 the US was down 32.6 percent year-on-year. Therefore, that particular trend will be watched out closely. Overall revenue up 10 percent, margins 16.5 percent odd, profit up 6.1 percent.
  • In Q2 of FY18 India was up 5.3 percent only so let us see what kind of trend sustains post goods and services tax (GST) restocking for Glenmark.
  •  
    Have you signed up for Primo, our daily newsletter? It has all the stories and data on the market, business, economy and tech that you need to know.